CreativeOne Wealth LLC Purchases New Position in Humana Inc. (NYSE:HUM)

CreativeOne Wealth LLC acquired a new stake in Humana Inc. (NYSE:HUM) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 656 shares of the insurance provider’s stock, valued at approximately $208,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in HUM. Cetera Investment Advisers raised its stake in shares of Humana by 249.0% during the first quarter. Cetera Investment Advisers now owns 20,945 shares of the insurance provider’s stock worth $7,262,000 after purchasing an additional 14,944 shares during the last quarter. Massmutual Trust Co. FSB ADV grew its holdings in Humana by 124.8% in the second quarter. Massmutual Trust Co. FSB ADV now owns 299 shares of the insurance provider’s stock valued at $112,000 after purchasing an additional 166 shares during the last quarter. CWM LLC boosted its stake in shares of Humana by 21.0% during the second quarter. CWM LLC now owns 3,175 shares of the insurance provider’s stock valued at $1,186,000 after acquiring an additional 552 shares during the last quarter. Valeo Financial Advisors LLC boosted its stake in shares of Humana by 9.0% during the second quarter. Valeo Financial Advisors LLC now owns 1,561 shares of the insurance provider’s stock valued at $583,000 after acquiring an additional 129 shares during the last quarter. Finally, CX Institutional boosted its stake in shares of Humana by 59.2% during the second quarter. CX Institutional now owns 9,674 shares of the insurance provider’s stock valued at $3,615,000 after acquiring an additional 3,599 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Stock Down 0.7 %

HUM opened at $291.10 on Wednesday. Humana Inc. has a one year low of $213.31 and a one year high of $502.73. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. The stock’s fifty day moving average is $274.51 and its 200-day moving average is $328.34. The company has a market capitalization of $35.05 billion, a PE ratio of 25.78, a P/E/G ratio of 2.31 and a beta of 0.53.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, topping analysts’ consensus estimates of $3.48 by $0.68. The company had revenue of $29.30 billion for the quarter, compared to the consensus estimate of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. On average, equities analysts predict that Humana Inc. will post 15.86 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.22%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana’s payout ratio is 31.36%.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on the company. Oppenheimer reduced their target price on Humana from $400.00 to $280.00 and set an “outperform” rating on the stock in a research report on Thursday, October 3rd. Sanford C. Bernstein upgraded Humana from a “market perform” rating to an “outperform” rating and set a $308.00 target price on the stock in a report on Tuesday, October 8th. TD Cowen raised their target price on Humana from $261.00 to $268.00 and gave the company a “hold” rating in a report on Monday, November 4th. Truist Financial lowered their price objective on Humana from $400.00 to $260.00 and set a “hold” rating for the company in a research note on Friday, October 11th. Finally, Piper Sandler lowered Humana from an “overweight” rating to a “neutral” rating and decreased their target price for the stock from $392.00 to $274.00 in a research report on Thursday, October 3rd. Twenty equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $315.86.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.